Want to see AU:FRE full AI Analyst Report?
Total Valuation
Firebrick Pharma Limited has a market cap or net worth of AU$8.90M. The enterprise value is AU$8.14M.
Market CapAU$8.90M
Enterprise ValueAU$8.14M
Share Statistics
Firebrick Pharma Limited has 287,198,970 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding287,198,970
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Firebrick Pharma Limited’s return on equity (ROE) is -1.82 and return on invested capital (ROIC) is -182.70%.
Return on Equity (ROE)-1.82
Return on Assets (ROA)-1.41
Return on Invested Capital (ROIC)-182.70%
Return on Capital Employed (ROCE)-1.84
Revenue Per Employee17.67K
Profits Per Employee-510.55K
Employee Count6
Asset Turnover0.05
Inventory Turnover3.14
Valuation Ratios
The current PE Ratio of Firebrick Pharma Limited is ―. Firebrick Pharma Limited’s PEG ratio is 0.75.
PE Ratio―
PS Ratio86.36
PB Ratio5.44
Price to FCF-3.52
Price to Operating Cash Flow-2.82
PEG Ratio0.75
Income Statement
In the last 12 months, Firebrick Pharma Limited had revenue of 106.03K and earned -3.06M in profits. Earnings per share was -0.01.
Revenue106.03K
Gross Profit-1.04M
Operating Income-3.10M
Pretax Income-3.09M
Net Income-3.06M
EBITDA-3.10M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -2.60M and capital expenditures 3.00, giving a free cash flow of -2.60M billion.
Operating Cash Flow-2.60M
Free Cash Flow-2.60M
Free Cash Flow per Share>-0.01
Dividends & Yields
Firebrick Pharma Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.16
52-Week Price Change-55.38%
50-Day Moving Average0.03
200-Day Moving Average0.04
Relative Strength Index (RSI)48.71
Average Volume (3m)92.71K
Important Dates
Firebrick Pharma Limited upcoming earnings date is Mar 2, 2027, TBA (Confirmed).
Last Earnings DateAug 31, 2026
Next Earnings DateMar 2, 2027
Ex-Dividend Date―
Financial Position
Firebrick Pharma Limited as a current ratio of 3.85, with Debt / Equity ratio of 0.00%
Current Ratio3.85
Quick Ratio3.10
Debt to Market Cap0.00
Net Debt to EBITDA0.43
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Firebrick Pharma Limited has paid -28.83K in taxes.
Income Tax-28.83K
Effective Tax Rate<0.01
Enterprise Valuation
Firebrick Pharma Limited EV to EBITDA ratio is -2.53, with an EV/FCF ratio of -3.01.
EV to Sales73.90
EV to EBITDA-2.53
EV to Free Cash Flow-3.01
EV to Operating Cash Flow-3.01
Balance Sheet
Firebrick Pharma Limited has AU$1.32M in cash and marketable securities with AU$0.00 in debt, giving a net cash position of AU$1.32M billion.
Cash & Marketable SecuritiesAU$1.32M
Total DebtAU$0.00
Net CashAU$1.32M
Net Cash Per Share<AU$0.01
Tangible Book Value Per Share<AU$0.01
Margins
Gross margin is -1063.73%, with operating margin of -2925.61%, and net profit margin of -2889.11%.
Gross Margin-1063.73%
Operating Margin-2925.61%
Pretax Margin-2916.30%
Net Profit Margin-2889.11%
EBITDA Margin-2921.29%
EBIT Margin-2925.61%
Analyst Forecast
The average price target for Firebrick Pharma Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-63.86%
EPS Growth Forecast4.00%